Study shows strong long-term survival rates for patients with GIST
Monday, February 20, 2017 - 11:01
in Health & Medicine
Nearly one in four patients with incurable gastrointestinal stromal tumors (GIST) treated with Gleevec will survive 10 years, a new report outlines.